levetiracetam

Product NDC: 10370-195
Requested package NDC: 10370-195-06
11-digit product format: 103700195
Labeler code: 10370
Product ID: 10370-195_a46e7248-dd69-4781-98a2-e08646630304
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: levetiracetam
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Route: ORAL
Labeler: Par Pharmaceutical, Inc.
Application: ANDA091360
Marketing category: ANDA
Marketing start: 2011-10-04
Marketing end: 0000-00-00
Substance: LEVETIRACETAM
Active strength: 500 mg/1
Pharmacologic classes: Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	10370-195	10370-195-06	D	Discontinued by firm		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 16 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Code, Status table
Captured / source date	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A091360-001	LEVETIRACETAM	LEVETIRACETAM	500MG	TABLET, EXTENDED RELEASE / ORAL			2011-10-04
A091360-002	LEVETIRACETAM	LEVETIRACETAM	750MG	TABLET, EXTENDED RELEASE / ORAL			2011-10-04

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A091360-001	LEVETIRACETAM	500MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A091360-002	LEVETIRACETAM	750MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A091360-001	LEVETIRACETAM	500MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A091360-002	LEVETIRACETAM	750MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091360-001	LEVETIRACETAM	500MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091360-002	LEVETIRACETAM	750MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A091360-001	LEVETIRACETAM	500MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A091360-002	LEVETIRACETAM	750MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091360-001	LEVETIRACETAM	500MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091360-002	LEVETIRACETAM	750MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091360-001	LEVETIRACETAM	500MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091360-002	LEVETIRACETAM	750MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091360-001	LEVETIRACETAM	500MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091360-002	LEVETIRACETAM	750MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091360-001	LEVETIRACETAM	500MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091360-002	LEVETIRACETAM	750MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091360-001	LEVETIRACETAM	500MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091360-002	LEVETIRACETAM	750MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091360-001	LEVETIRACETAM	500MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091360-002	LEVETIRACETAM	750MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A091360-001	LEVETIRACETAM	500MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A091360-002	LEVETIRACETAM	750MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A091360-001	LEVETIRACETAM	500MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A091360-002	LEVETIRACETAM	750MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A091360-001	LEVETIRACETAM	500MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A091360-002	LEVETIRACETAM	750MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A091360-001	LEVETIRACETAM	500MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A091360-002	LEVETIRACETAM	750MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A091360-001	LEVETIRACETAM	500MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A091360-002	LEVETIRACETAM	750MG	TABLET, EXTENDED RELEASE / ORAL		2011-10-04	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A091360-001	LEVETIRACETAM	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2011-10-04	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A091360-002	LEVETIRACETAM	750MG	TABLET, EXTENDED RELEASE / ORAL	AB	2011-10-04	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A091360-001	LEVETIRACETAM	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2011-10-04	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A091360-002	LEVETIRACETAM	750MG	TABLET, EXTENDED RELEASE / ORAL	AB	2011-10-04	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A091360-001	LEVETIRACETAM	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2011-10-04	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A091360-002	LEVETIRACETAM	750MG	TABLET, EXTENDED RELEASE / ORAL	AB	2011-10-04	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A091360-001	LEVETIRACETAM	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2011-10-04	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A091360-002	LEVETIRACETAM	750MG	TABLET, EXTENDED RELEASE / ORAL	AB	2011-10-04	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A091360-001	LEVETIRACETAM	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2011-10-04	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A091360-002	LEVETIRACETAM	750MG	TABLET, EXTENDED RELEASE / ORAL	AB	2011-10-04	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 50 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A091360-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A091360-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A091360-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A091360-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A091360-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A091360-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A091360-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A091360-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A091360-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A091360-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A091360-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A091360-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A091360-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A091360-002	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A091360-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A091360-002	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A091360-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A091360-002	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A091360-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A091360-002	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A091360-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A091360-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A091360-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A091360-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A091360-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A091360-002	AB	1	`ea99ee380514…`
2024-02-18 07:12 UTC	2024-02	A091360-001	AB	1	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	A091360-002	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A091360-001	AB	1	`ea1830bbd6c7…`
2023-12-20 04:57 UTC	2023-12	A091360-002	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A091360-001	AB	1	`a72a2bbeb626…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A091360-002	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A091360-001	AB	1	`9b2671bbb829…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A091360-002	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A091360-001	AB	1	`a67488948f0b…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A091360-002	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A091360-001	AB	1	`3f0d92c62455…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A091360-002	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A091360-001	AB	1	`053a50430f4f…`
2023-05-13 08:27 UTC	2023-05	A091360-002	AB	1	`053a50430f4f…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
10370-195-06	2025-01-29	These highlights do not include all the information needed to use EXTENDED-RELEASE LEVETIRACETAM TABLETS safely and effectively. See full prescribing information for EXTENDED-RELEASE LEVETIRACETAM TABLETS. Levetiracetam Extended-Release Tablets, for oral use. Initial U.S. Approval: 1999
10370-195-09	2025-01-29	These highlights do not include all the information needed to use EXTENDED-RELEASE LEVETIRACETAM TABLETS safely and effectively. See full prescribing information for EXTENDED-RELEASE LEVETIRACETAM TABLETS. Levetiracetam Extended-Release Tablets, for oral use. Initial U.S. Approval: 1999
10370-195-50	2025-01-29	These highlights do not include all the information needed to use EXTENDED-RELEASE LEVETIRACETAM TABLETS safely and effectively. See full prescribing information for EXTENDED-RELEASE LEVETIRACETAM TABLETS. Levetiracetam Extended-Release Tablets, for oral use. Initial U.S. Approval: 1999
10370-195-06	2022-07-29	These highlights do not include all the information needed to use EXTENDED-RELEASE LEVETIRACETAM TABLETS safely and effectively. See full prescribing information for EXTENDED-RELEASE LEVETIRACETAM TABLETS. Levetiracetam Extended-Release Tablets, for oral use. Initial U.S. Approval: 1999
10370-195-09	2022-07-29	These highlights do not include all the information needed to use EXTENDED-RELEASE LEVETIRACETAM TABLETS safely and effectively. See full prescribing information for EXTENDED-RELEASE LEVETIRACETAM TABLETS. Levetiracetam Extended-Release Tablets, for oral use. Initial U.S. Approval: 1999
10370-195-50	2022-07-29	These highlights do not include all the information needed to use EXTENDED-RELEASE LEVETIRACETAM TABLETS safely and effectively. See full prescribing information for EXTENDED-RELEASE LEVETIRACETAM TABLETS. Levetiracetam Extended-Release Tablets, for oral use. Initial U.S. Approval: 1999

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
10370-195-06	EA - Each	10370-195	4cd5b5fc-29d0-4b1e-9213-8056c06e94d9	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
LEVETIRACETAM	ACTIVE INGREDIENT	44YRR34555	LEVETIRACETAM EXTENDED-RELEASE (LEVETIRACETAM) TABLET, FILM COATED, EXTENDED RELEASE [ANCHEN PHARMACEUTICALS, INC.]	5
LEVETIRACETAM	ACTIVE MOIETY	44YRR34555	LEVETIRACETAM EXTENDED-RELEASE (LEVETIRACETAM) TABLET, FILM COATED, EXTENDED RELEASE [ANCHEN PHARMACEUTICALS, INC.]	5
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	LEVETIRACETAM EXTENDED-RELEASE (LEVETIRACETAM) TABLET, FILM COATED, EXTENDED RELEASE [ANCHEN PHARMACEUTICALS, INC.]	5
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	LEVETIRACETAM EXTENDED-RELEASE (LEVETIRACETAM) TABLET, FILM COATED, EXTENDED RELEASE [ANCHEN PHARMACEUTICALS, INC.]	5
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	LEVETIRACETAM EXTENDED-RELEASE (LEVETIRACETAM) TABLET, FILM COATED, EXTENDED RELEASE [ANCHEN PHARMACEUTICALS, INC.]	5
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LEVETIRACETAM EXTENDED-RELEASE (LEVETIRACETAM) TABLET, FILM COATED, EXTENDED RELEASE [ANCHEN PHARMACEUTICALS, INC.]	5
POLYETHYLENE GLYCOL	INACTIVE INGREDIENT	3WJQ0SDW1A	LEVETIRACETAM EXTENDED-RELEASE (LEVETIRACETAM) TABLET, FILM COATED, EXTENDED RELEASE [ANCHEN PHARMACEUTICALS, INC.]	5
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	LEVETIRACETAM EXTENDED-RELEASE (LEVETIRACETAM) TABLET, FILM COATED, EXTENDED RELEASE [ANCHEN PHARMACEUTICALS, INC.]	5
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	LEVETIRACETAM EXTENDED-RELEASE (LEVETIRACETAM) TABLET, FILM COATED, EXTENDED RELEASE [ANCHEN PHARMACEUTICALS, INC.]	5
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	LEVETIRACETAM EXTENDED-RELEASE (LEVETIRACETAM) TABLET, FILM COATED, EXTENDED RELEASE [ANCHEN PHARMACEUTICALS, INC.]	5
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LEVETIRACETAM EXTENDED-RELEASE (LEVETIRACETAM) TABLET, FILM COATED, EXTENDED RELEASE [ANCHEN PHARMACEUTICALS, INC.]	5

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
44YRR34555	LEVETIRACETAM	102767-28-2	LEVETIRACETAM

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
10370-195-06	10370019506	60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (10370-195-06)	2011-10-04	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
levetiracetam extended-release	Par Pharmaceutical, Inc.	2018-12-04	HUMAN PRESCRIPTION DRUG LABEL	11